A Review of Quality of Life in Alzheimer's Disease: Part 2: Issues in Assessing Drug Effects

Author： Salek S.S.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.6, 1998-12, pp. : 613-627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects

By McKenna S.P.   Doward L.C.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 417-419

Adis International

Access to resources Recommend Favorite

A Review of Quality of Life in Alzheimer’s Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects

By Greer M.   Monteban H.  

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 641-644

Adis International

Access to resources Recommend Favorite

A Review of Quality of Life in Alzheimer's Disease: Part 1: Issues in Assessing Disease Impact

By Walker M.D.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 499-530

Adis International

Access to resources Recommend Favorite

Functional Outcomes of Drug Treatment in Alzheimer's Disease: A Systematic Review and Meta-Analysis

By Hansen Richard A.  

Drugs & Aging, Vol. 24, Iss. 2, 2007-01 ,pp. : 155-167

Adis International

Access to resources Recommend Favorite

Current and Emerging Drug Treatment Options for Alzheimer's Disease: A Systematic Review

By Herrmann Nathan   Chau Sarah A.   Kircanski Ida   Lanctôt Krista L.  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2031-2065

Adis International

Access to resources Recommend Favorite